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Abstract
Background and study aims—Complete stone removal from the main pancreatic duct might 
not be achieved in all patients with obstructive chronic calcific pancreatitis. We report our results 
for endoscopic dorsal pancreatic duct (DPD) bypass of obstructing stones in the ventral pancreatic 
duct (VPD).
Patients and methods—16 patients with obstructive chronic calcific pancreatitis were treated 
with a DPD bypass. Clinical success was defined as significant pain relief and no hospital 
admissions for pain management during the ongoing treatment period.
Results—Among 16 patients meeting entry criteria, 10 (62.5%) had a history of unsuccessful 
endoscopic therapy, and 8 had failed extracorporeal shockwave lithotripsy (ESWL). Clinical 
success was achieved in 12 patients (75 %). Among these responders, 10 patients (83.3 %) had 
markedly improved or complete pain relief after the first stent placement, which persisted 
throughout the follow-up period; 11 patients (91.7 %) were able to discontinue their daily 
analgesics.
Conclusions—In selected patients with obstructive chronic calcific pancreatitis, the DPD bypass 
may be considered as a rescue endoscopic therapy, potentially obviating the need for surgery when 
standard endoscopic methods and ESWL fail.
Introduction
For selected patients with obstructive chronic calcific pancreatitis (CCP), endoscopic 
decompression of the main pancreatic duct (MPD) at endoscopic retrograde 
cholangiopancreatography (ERCP) is a reasonable first-line approach and alternative to 
surgery [1 – 6]. Despite technological advances, including extracorporeal shockwave 
lithotripsy (ESWL) and electrohydraulic lithotripsy, complete MPD stone removal is 
achieved in only 44 % – 75 % of cases [7]. In a proportion of patients, obstructive CCP is 
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refractory to initial endoscopic attempts at duct clearance, and additional procedures are 
required. Obstructing pancreatic stones may be accompanied by a MPD stricture in 60 % – 
70 % of cases [4, 5]. Failure to pass a guidewire or stone retrieval instruments through this 
stricture or beyond an impacted stone in the MPD precludes stone extraction [1, 8]. 
Alternative methods and strategies are therefore needed.
On occasion, the accessory duct take-off from the MPD may be identified upstream to an 
obstructing stone, in the head of the pancreas. Decompression of the dorsal pancreatic ductal 
system may be accomplished by intervention at the minor papilla [9]. Placement of a stent 
into the dorsal pancreatic duct (DPD) serves to bypass the stone and/or stricture in the 
ventral pancreatic duct (VPD), allowing decompression of the MPD and potentially offering 
symptomatic relief. The aim of this study was to evaluate the efficacy of the endoscopic 
DPD bypass in patients with obstructing VPD stones.
Patients and methods
This study was approved by the Indiana University Institutional Review Board (IU-IRB No. 
1506157608). All patients with symptomatic CCP who underwent ERCP at Indiana 
University Hospital between January 2002 and May 2015 were retrospectively identified 
from our procedure database. All cases of successful or failed minor papilla cannulation 
were also included in our initial search to facilitate patient identification. The diagnosis of 
CCP was based on computed tomography (CT) and/or ERCP findings. Patients were eligible 
for study inclusion if, after failed attempts to bypass/remove stones through the VPD, a 
pancreatic duct stent had been placed via the minor papilla into the MPD, bypassing an 
obstructing stone in the head of the pancreas downstream. No patients were identified from 
our database who had obstructing VPD stones and in whom minor papilla cannulation had 
been attempted and failed. Patients with pancreas divisum or ansa pancreatica were 
excluded. During the study period, 16 patients were treated with the endoscopic DPD 
bypass.
Baseline clinical data, including etiology of CCP, previous therapy, pain character/intensity, 
analgesics used, and presence of other associated symptoms, were collected from the 
patients’ charts. Endoscopic data were collected from procedure reports and review of 
fluoroscopic images and included: VPD stone character, presence of VPD stricture, maximal 
MPD diameter, DPD dilation method, and stent size and number placed. Clinical follow-up 
data were obtained by chart review as follows: change of pain character/intensity and 
analgesic use, pain-free or pain-improvement interval, further hospital admission(s), need for 
surgery, and changes in other associated symptoms. Clinical success was defined as 
significant pain improvement where the patient was satisfied with the degree of pain relief, 
and no further hospital admissions for pain management after DPD therapy during the study 
period.
The endoscopic DPD bypass technique is illustrated in ▶Fig. 1 and ▶Fig. 2. Single or 
multiple large or obstructing stones in the VPD in the pancreatic head are confirmed on 
ERCP examination. The VPD is obstructed by the stone(s) and/ or stricture, precluding 
passage of instruments upstream. In patients where the DPD is visualized after VPD contrast 
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injection, DPD cannulation is attempted. If initial DPD cannulation fails, cannulation with a 
rendezvous method (guidewire insertion through the major papilla and out the minor papilla) 
may be attempted (▶Fig. 3a,b). After successful DPD cannulation, dorsal pancreatic 
sphincterotomy is performed and a pancreatic stent is placed via the minor papilla. In most 
cases, we perform DPD dilation prior to attempting stent insertion (▶Fig. 3c), particularly if 
the accessory duct is of small caliber.
If the patient notes initial improvement, additional treatments with repeated stent placement 
are performed until the DPD bypass tract is sufficiently dilated to allow for adequate 
pancreatic ductal drainage.
Results
Baseline clinical data and ERCP findings are summarized in ▶Table 1. Among 16 patients 
meeting entry criteria, 10 patients (62.5%) had a history of prior unsuccessful endoscopic 
treatment via the VPD, i. e. at a previous ERCP. ESWL (with or without endoscopic 
pancreatic sphincterotomy) had been previously employed unsuccessfully in 8 of the 16 
patients. ESWL had not been attempted in the remaining 8 patients. Therapy via the VPD 
had ultimately failed in all 16 patients, prior to attempted minor papilla cannulation at the 
same ERCP. Nearly all patients (15/16) had multiple (> 2) VPD stones, and the mean 
(standard deviation [SD]) maximal stone diameter was 9.5 (3.5) mm, with a dilated MPD 
upstream. A VPD stricture downstream of the stone(s) was identified in 14/16 patients, with 
failed VPD visualization in 2 patients. However, subsequent pancreatography performed via 
the minor papilla excluded pancreas divisum anatomy, with visualization of the ventral 
system.
The technical outcomes and follow-up data of endoscopic therapy are reported in ▶Table 2. 
Clinical success was achieved in 12 patients (75 %). Initial DPD dilation was performed in 
15 patients (94 %). With a beneficial response to initial DPD stenting, additional ERCPs 
with stent upsizing was often performed, with a maximum of 4 simultaneous stents placed in 
this series. Removal of small stones in the upstream pancreatic duct was also performed via 
the dorsal duct/minor papilla in 5 of 12 responders (41.7 %).
Of the 12 patients with clinical success, 10 (83.3 %) had markedly improved or complete 
pain relief after initial stent placement (including improved steatorrhea in one patient who 
underwent DPD bypass for this indication), a benefit which persisted throughout the stenting 
interval. The other 2 patients (16.7 %) had markedly improved pain levels, in one case after 
placement of the second stent and in the other after final stent removal (▶Fig. 4). During the 
ongoing treatment period after DPD stenting, including treatment periods after stent removal 
(median 196 days, range 56 – 809), 11/12 responders (92 %) were able to discontinue 
analgesics entirely, 1 patient was able to have a dose reduction, and no patient required 
pancreatic surgery. In addition, when present, other symptoms or signs attributed to chronic 
pancreatitis dramatically improved in 6 of 9 patients who also experienced clinical success 
with a decrease in pain.
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The stent indwelling time for responders ranged from 56 to 425 days (median 161 days). 
One patient had a stent in place for an extended period (506 days) because of severe co-
morbidity. Additional intervention was not attempted or required during the follow-up 
period in any of the 8 responders whose stents could be removed. Post-ERCP complications 
[10] were limited to 1 mild post-sphincterotomy bleed (6.3 %) that spontaneously stopped 
without need for additional endoscopic hemostatic maneuvers.
Among the 4 patients with treatment failure (25 %) with persistent pain, 1 patient underwent 
a Frey procedure, 1 had a gastrojejunal feeding tube placed for pancreatic rest when surgical 
options were not preferred by the patient, and 2 were managed with increased analgesics 
alone, without additional endoscopic or surgical therapy.
Discussion
For patients with intractable pain from obstructive CCP, repeated endoscopic procedures or 
surgery may be required. Pancreatic endotherapy, with or without ESWL, in patients with 
CCP can provide good short-term relief of pain with appropriate patient selection [8]. 
Furthermore, long-term pain relief has been reported in 57 % of patients 5 years after final 
stent removal [11]. However, approximately one-third of patients are unable to complete 
definitive endoscopic therapy, with incomplete duct clearance, and often require surgery [4, 
5].
When traditional endoscopic methods via the major papilla fail because of inability to 
traverse a stricture and/or obstructing VPD stone(s), the DPD bypass method should be 
considered as an alternative approach. We acknowledge that minor papilla interventions are 
frequently employed in patients without pancreas divisum, and endoscopic DPD intervention 
has previously been reported as a technically feasible method in CCP [9]. However, this is 
the first report of the DPD bypass method with pancreatic duct stenting in CCP with 
subsequent clinical improvement.
We herein present our experience using this technique in 16 patients, in whom short-term 
clinical success was achieved in 12 (75 %). We anticipate that this bypass technique will 
have results comparable to standard ERCP maneuvers when the MPD is cleared of 
obstructing stones, although additional follow-up data are required. Currently, follow-up 
data are available in only 6 patients following final stent removal in this series (▶Fig. 4). 
However, our preliminary data suggest that the success of this DPD approach may be 
predicted by the response to initial stent placement.
The limitations of this study are the retrospective design, limited number of patients, lack of 
a validated pain questionnaire used to assess outcomes, and limited follow-up. Furthermore, 
it is possible that additional patients may have undergone attempted DPD bypass but 
insufficient or inadequate documentation in our ERCP database or the medical record may 
have precluded identification. The retrospective nature of our report makes success rates 
difficult to determine with complete accuracy, as entry into the database may not be uniform, 
making it difficult to identify all potential candidates. However, in this series, 16 patients 
with CCP were identified in whom endotherapy via the ventral system failed, and in 12 
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dorsal duct drainage via the minor papilla showed a short-term clinical success (i. e., a 
clinical success rate of 75 %).
In conclusion, in selected patients with obstructive CCP in whom standard endoscopic 
approaches, including ESWL, have failed, endoscopic DPD bypass is feasible and provides 
at least short-term clinical benefit in the majority of treated patients. This technique may be 
considered as a rescue method for obviating surgery in patients with refractory obstructing 
stones in the VPD.
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Fig. 1. 
Illustration of the dorsal pancreatic duct (DPD) bypass method. a The ventral pancreatic 
duct in the head is partially obstructed by a large stone upstream from a stricture. b A 
guidewire cannot be inserted beyond the stone. c Contrast injection opacifies the main 
pancreatic duct (MPD), branch ducts, and a narrow DPD. d A guidewire is successfully 
advanced into the DPD, allowing subsequent dorsal pancreatic sphincterotomy and stent 
placement into the MPD via the minor papilla.
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Fig. 2. 
Two representative cases illustrating the dorsal pancreatic duct (DPD) bypass. a – d A 47-
year-old woman had experienced numerous pain flares of chronic pancreatitis. a The ventral 
pancreatic duct contains several complex stones in the head of the pancreas. b A high grade 
2-mm stenosis immediately upstream from the stones is seen in the ventral pancreatic duct 
and cannot be crossed with a highly tapered catheter. c The DPD take-off is upstream from 
the large stone, and deep cannulation of the DPD is accomplished. d After dorsal pancreatic 
sphincterotomy and dilation with a 4-mm balloon dilator, a 5-Fr pancreatic stent is 
successfully placed into the DPD. e – h A 70-year-old man had established chronic recurrent 
pancreatitis. e A conglomeration of large stones is noted fluoroscopically in the head of the 
pancreas. Cannulation and visualization of the ventral pancreatic duct failed. f 
Pancreatography via DPD cannulation shows multiple large obstructing stones in the ventral 
pancreatic duct in the head of the pancreas. The duct is obstructed by stones in the body. g, h 
After dorsal pancreatic sphincterotomy and dilation with a 6-mm balloon dilator, two 
pancreatic stents are successfully placed into the main pancreatic duct.
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Fig. 3. 
a, b After ventral pancreatic duct cannulation via the major papilla, a guidewire is passed 
through the accessory duct, exiting the minor papilla and facilitating dorsal duct cannulation. 
c Endoscopic image illustrating dorsal duct dilation with a 6-mm balloon dilator.
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Fig. 4. 
Pain improvement following dorsal pancreatic duct (DPD) bypass (see text).
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Table 1
Patients with chronic calcific pancreatitis (CCP) treated with endoscopic dorsal pancreatic duct bypass (n = 
16): clinical data and endoscopic retrograde cholangiopancreatography (ERCP) findings.
Age, median (mean [SD]), years 59.5 (39.0 [11.2])
Sex, male : female, n   8 : 8
Etiology of chronic pancreatitis, n (%)
▪ Alcohol   9 (56.3)
▪ Smoking   2 (12.5)
▪ Idiopathic   5 (31.3)
Pain (or main symptom) pattern, n (%)
▪ Daily 10 (62.5)
 – Severe   7
 – Moderate   2
 – Mild   1
▪ Intermittent   6 (37.5)
 – Severe   3
 – Moderate   3
 – Mild   0
Other symptoms or signs attributed to CCP, n (%)
▪ At least one symptom or sign 11 (68.8)
▪ Weight loss   6 (37.5)
▪ Steatorrhea or diarrhea   6 (37.5)
▪ Diabetes   6 (37.5)
▪ Jaundice   1 (6.3)
▪ Ascites   1 (6.3)
Previous treatment, n (%) 10 (62.5)
▪ ERCP with endoscopic pancreatic sphincterotomy   2
▪ Extracorporeal shock wave lithotripsy (ESWL)   2
▪ Both 6
Number of stone(s) in ventral pancreatic duct, n (%) patients
▪ Multiple (> 2) stones 15 (93.8)
▪ 2 stones   1 (6.3)
▪ 1 stone   0
Maximal diameter of stone in ventral pancreatic duct, median (mean [SD]), mm   9 (9.5 [3.5])
Maximal diameter of main pancreatic duct upstream from stone, towards tail, median (mean [SD]), mm   8 (8.8 [3.5])
Ventral pancreatic duct stricture length downstream from stone, towards head, median (mean [SD]), mm 10 (9.8 [4.8])
SD, standard deviation.
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Table 2
Chronic calcific pancreatitis (CCP) treated with endoscopic dorsal pancreatic duct bypass (n = 16 patients): 
technical data and follow-up results.
Initial dorsal pancreatic duct dilation, n (%)   15 (94.0)
▪ Catheter dilator   11
 – 3-4-5 Fr alone     8
 – 3-4-5 Fr + 4-5-7 Fr     2
 – 3-4-5 Fr + 5-7-8.5 Fr     1
▪ Balloon dilator     1
▪ Both     3
 – 4-mm balloon dilator + catheter dilator     1
 – 6-mm balloon dilator + catheter dilator (One patient underwent dilation with the 4-mm followed by the 6-mm 
balloon)
    3
Number of stents placed at initial ERCP, n patients
▪ 1 stent   13
▪ 2 stents     3
Maximal diameter of initial stent, n patients
▪ 7 Fr     7
▪ 6 Fr     3
▪ 5 Fr     3
▪ 4 Fr     3
Length of initial stent, median (mean [SD]), cm     8 (8.1 [2.7])
Clinical success, n (%)   12 (75.0)
Total ERCP sessions in 12 patients with clinical success, n patients
▪ 1 session     2
▪ 2 sessions     6
▪ 3 sessions     3
▪ 4 sessions     1
Maximum number of final stents placed at one time in 12 patients with clinical success, n patients
▪ 1 stent     7
▪ 2 stents     3
▪ 3 stents     1
▪ 4 stents     1
Length of final stent in patients with clinical success, median (mean [SD]), cm     8 (8.7 [2.7])
Stenting duration in patients with clinical success, median (mean [SD]), days 161 (163.1 [113.4])
Pain (or major symptom) relief in patients with clinical success, n   12
▪ After 1st stent placement   10
▪ After 2nd stent placement or final stent removal     2
Changes in pain relief medication in patients with clinical success, n   12
▪ Discontinuation/stop   11
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▪ Dose reduction     1
Changes of other symptoms and signs in patients with clinical success     9
▪ Markedly improved     6
▪ Non-improved     3
ERCP, endoscopic retrograde cholangiopancreatography; SD, standard deviation
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